Your browser doesn't support javascript.
loading
High Keratin-7 Expression in Benign Peri-Tumoral Prostatic Glands Is Predictive of Bone Metastasis Onset and Prostate Cancer-Specific Mortality.
Dariane, Charles; Clairefond, Sylvie; Péant, Benjamin; Communal, Laudine; Thian, Zhe; Ouellet, Véronique; Trudel, Dominique; Benzerdjeb, Nazim; Azzi, Feryel; Méjean, Arnaud; Timsit, Marc-Olivier; Baurès, Manon; Guidotti, Jacques-Emmanuel; Goffin, Vincent; Karakiewicz, Pierre I; Mes-Masson, Anne-Marie; Saad, Fred.
Afiliação
  • Dariane C; Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM), Institut du Cancer de Montréal (ICM), Montréal, QC H2X 0A9, Canada.
  • Clairefond S; Department of Urology, Hôpital Européen Georges-Pompidou, Université de Paris, F-75006 Paris, France.
  • Péant B; Institut Necker Enfants Malades (INEM), Inserm U1151, Université de Paris, F-75006 Paris, France.
  • Communal L; Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM), Institut du Cancer de Montréal (ICM), Montréal, QC H2X 0A9, Canada.
  • Thian Z; Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM), Institut du Cancer de Montréal (ICM), Montréal, QC H2X 0A9, Canada.
  • Ouellet V; Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM), Institut du Cancer de Montréal (ICM), Montréal, QC H2X 0A9, Canada.
  • Trudel D; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, QC H2X 0A9, Canada.
  • Benzerdjeb N; Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM), Institut du Cancer de Montréal (ICM), Montréal, QC H2X 0A9, Canada.
  • Azzi F; Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM), Institut du Cancer de Montréal (ICM), Montréal, QC H2X 0A9, Canada.
  • Méjean A; Department of Pathology, Centre Hospitalier Universitaire Lyon Sud, F-69310 Pierre-Bénite, France.
  • Timsit MO; Department of Pathology, Centre Hospitalier Universitaire Lyon Sud, F-69310 Pierre-Bénite, France.
  • Baurès M; Department of Pathology and Cellular Biology, Centre Hospitalier de l'Université de Montréal (CHUM), 1000 rue St Denis, Montréal, QC H2X 0C1, Canada.
  • Guidotti JE; Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM), Institut du Cancer de Montréal (ICM), Montréal, QC H2X 0A9, Canada.
  • Goffin V; Department of Pathology and Cellular Biology, Centre Hospitalier de l'Université de Montréal (CHUM), 1000 rue St Denis, Montréal, QC H2X 0C1, Canada.
  • Karakiewicz PI; Department of Urology, Hôpital Européen Georges-Pompidou, Université de Paris, F-75006 Paris, France.
  • Mes-Masson AM; Department of Urology, Hôpital Européen Georges-Pompidou, Université de Paris, F-75006 Paris, France.
  • Saad F; Institut Necker Enfants Malades (INEM), Inserm U1151, Université de Paris, F-75006 Paris, France.
Cancers (Basel) ; 14(7)2022 Mar 23.
Article em En | MEDLINE | ID: mdl-35406395
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article